Swedbank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BC
Swedbank's XBI Position: Q2 2025 in Review
Swedbank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 170,643 shares — an estimated $13.8M sold.
Swedbank first reported a position in XBI in Q3 2024 and held it in 3 quarters. The position peaked at $22.8M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Swedbank reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Swedbank sold 170,643 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $13.8M.
- Swedbank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and held it in 3 quarters.
- Swedbank's State Street SPDR S&P Biotech ETF position peaked at $22.8M in Q3 2024.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Swedbank's 13F filing for Q2 2025, filed 10 Jul 2025.